The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999)

被引：0
|
作者：
Vaillancourt, M
Irlbeck, D
Smith, T
Coombs, RW
Swanstrom, R
机构：
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1999年 / 15卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：949 / 949
页数：1
相关论文
共 50 条
  • [21] Exploring molecular mechanism of allosteric inhibitor to relieve drug resistance of multiple mutations in HIV-1 protease by enhanced conformational sampling
    Chen, Jianzhong
    Peng, Cheng
    Wang, Jinan
    Zhu, Weiliang
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2018, 86 (12) : 1294 - 1305
  • [22] Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients (vol 128, pg 906, 1998)
    Shafer, RW
    Winters, MA
    Palmer, S
    Merigan, TC
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) : 1083 - 1083
  • [23] Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
    Malet, Isabelle
    Subra, Frederic
    Charpentier, Charlotte
    Collin, Gilles
    Descamps, Diane
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Delelis, Olivier
    MBIO, 2017, 8 (05):
  • [24] Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment
    Kagan, R. M.
    Cheung, P. K.
    Huard, T. K.
    Lewinski, M. A.
    ANTIVIRAL RESEARCH, 2006, 71 (01) : 42 - 52
  • [25] MULTIPLE MUTATIONS IN HIV-1 REVERSE-TRANSCRIPTASE CONFER HIGH-LEVEL RESISTANCE TO ZIDOVUDINE (AZT)
    LARDER, BA
    KEMP, SD
    SCIENCE, 1989, 246 (4934) : 1155 - 1158
  • [26] Interplay between Single Resistance-Associated Mutations in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor Sensitivity
    Henderson, Gavin J.
    Lee, Sook-Kyung
    Irlbeck, David M.
    Harris, Janera
    Kline, Melissa
    Pollom, Elizabeth
    Parkin, Neil
    Swanstrom, Ronald
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 623 - 633
  • [27] Understanding how the G48T/L89M mutations reduce the effiicacy of the HIV-1 protease inhibitor saquinavir
    McGee, T. Dwight, Jr.
    Roitberg, Adrian E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [28] Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
    Su, Chinh Tran-To
    Koh, Darius Wen-Shuo
    Gan, Samuel Ken-En
    MOLECULES, 2019, 24 (18):
  • [29] Tipranavir resistance associated mutations in protease inhibitor-naive patients with HIV-1 subtype A/E infection
    Sungkanuparph, Somnuek
    Sukasem, Chonlaphat
    Manosuthi, Weerawat
    Wiboonchutikul, Surasak
    Piyavong, Bucha
    Chantratita, Wasun
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (03) : 284 - 286
  • [30] NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations
    Ishima, Rieko
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (6-7) : 365 - 374
12345